Furthermore, TP53 mutations, which are predominantly associated with non-endometrioid and poorly differentiated endometrioid carcinomas, are also found in approximately 9% of well-differentiated endometrioid carcinomas (25). This evidence concerns the gene TP53 and endometrioid adenocarcinoma.